Celemics, Inc.

331920 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ
₩13,800.00
-1.85%
Delayed · cached 15 min

Fair value analysis

Reported earnings per share are negative or zero, so the earnings-based models cannot produce a value.

Financial DNA score 19 / 100

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.